OTCPK:SCND

Stock Analysis Report

Executive Summary

Scientific Industries, Inc. provides benchtop laboratory equipment, customized catalyst research instruments, and bioprocessing systems and products worldwide.

Snowflake

Fundamentals

Excellent balance sheet and good value.

Share Price & News

How has Scientific Industries's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

16.1%

SCND

1.2%

US Medical Equipment

1.0%

US Market


1 Year Return

178.6%

SCND

14.9%

US Medical Equipment

8.0%

US Market

Return vs Industry: SCND exceeded the US Medical Equipment industry which returned 14.9% over the past year.

Return vs Market: SCND exceeded the US Market which returned 8% over the past year.


Shareholder returns

SCNDIndustryMarket
7 Day16.1%1.2%1.0%
30 Day47.7%-2.7%-0.07%
90 Day105.3%-1.7%-1.0%
1 Year181.8%178.6%15.8%14.9%10.4%8.0%
3 Year226.8%219.7%71.4%66.2%46.2%36.7%
5 Year155.6%150.0%124.3%99.7%64.3%46.2%

Price Volatility Vs. Market

How volatile is Scientific Industries's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Scientific Industries undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SCND ($9.75) is trading below our estimate of fair value ($112.13)

Significantly Below Fair Value: SCND is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SCND is good value based on its PE Ratio (22.6x) compared to the Medical Equipment industry average (42.1x).

PE vs Market: SCND is poor value based on its PE Ratio (22.6x) compared to the US market (17.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SCND's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SCND is good value based on its PB Ratio (2.3x) compared to the US Medical Equipment industry average (3.7x).


Next Steps

Future Growth

How is Scientific Industries forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

8.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SCND's forecast earnings growth (8.5% per year) is above the savings rate (2.7%).

Earnings vs Market: SCND's earnings (8.5% per year) are forecast to grow slower than the US market (14.5% per year).

High Growth Earnings: SCND's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if SCND's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if SCND's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SCND's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Scientific Industries performed over the past 5 years?

32.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: SCND has become profitable over the past 5 years, growing earnings by 32% per year.

Accelerating Growth: SCND has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: SCND has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).


Return on Equity

High ROE: SCND's Return on Equity (10.2%) is considered low.


Return on Assets

ROA vs Industry: SCND has a higher Return on Assets than the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: SCND has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Scientific Industries's financial position?


Financial Position Analysis

Short Term Liabilities: SCND's short term assets ($6.6M) exceeds its short term liabilities ($1.6M)

Long Term Liabilities: SCND's short term assets (6.6M) exceeds its long term liabilities (350.0K)


Debt to Equity History and Analysis

Debt Level: SCND's debt to equity ratio (2.2%) is considered satisfactory

Reducing Debt: SCND's debt to equity ratio has increased from 0.5% to 2.2% over the past 5 years.

Debt Coverage: SCND's debt is well covered by operating cash flow (828.2%).

Interest Coverage: SCND earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: SCND has a high level of physical assets or inventory.

Debt Coverage by Assets: SCND's debt is covered by short term assets (assets are 47.079280x debt).


Next Steps

Dividend

What is Scientific Industries's current dividend yield, its reliability and sustainability?

0.51%

Current Dividend Yield


Dividend Yield vs Market

company0.5%marketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: SCND's dividend (0.51%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.44%).

High Dividend: SCND's dividend (0.51%) is low compared to the top 25% of dividend payers in the US market (3.68%).

Stable Dividend: SCND is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: SCND is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: SCND is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SCND's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Scientific Industries's salary, the management and board of directors tenure and is there insider trading?

17.2yrs

Average management tenure


CEO

Helena Santos (55yo)

17.2yrs

Tenure

US$198,300

Compensation

Ms. Helena R. Santos, CPA., has been the President, Chief Executive Officer and Treasurer of Scientific Industries Inc. since August 29, 2002. Ms. Santos serves as the Chief Financial Officer and Complianc ...


CEO Compensation Analysis

Compensation vs. Market: Helena's total compensation ($USD198.30K) is below average for companies of similar size in the US market ($USD509.77K).

Compensation vs Earnings: Helena's compensation has been consistent with company performance over the past year.


Management Age and Tenure

17.2yrs

Average Tenure

56.5yo

Average Age

Experienced Management: SCND's management team is seasoned and experienced (17.2 years average tenure).


Board Age and Tenure

10.8yrs

Average Tenure

63yo

Average Age

Experienced Board: SCND's board of directors are seasoned and experienced ( 10.8 years average tenure).


Insider Trading

Insider Buying: SCND insiders have bought and sold the same number of shares in the past 3 months.


Recent Insider Transactions

SellUS$77,70007 Oct 19
Joseph Cremonese
EntityIndividual
Role
Chairman of the Board
Chairman
Shares22,200
Max PriceUS$3.50
BuyUS$77,70007 Oct 19
John Moore
EntityIndividual
Role
Member of the Board of Directors
Director
Shares22,200
Max PriceUS$3.50

Ownership Breakdown


Management Team

  • Helena Santos (55yo)

    CEO, President

    • Tenure: 17.2yrs
    • Compensation: US$198.30k
  • Robert Nichols (58yo)

    President of Genie Products Division - the Benchtop Laboratory Equipment Operations & Secretary

    • Tenure: 17.2yrs
    • Compensation: US$168.30k
  • Joseph Cremonese (83yo)

    Chairman

    • Tenure: 13.7yrs
    • Compensation: US$84.40k
  • Brookman March (74yo)

    VP of Corporate Development & Strategy and VP of Sales of Altamira

    • Tenure: 2.3yrs
    • Compensation: US$169.90k
  • Karl Nowosielski (40yo)

    President of Torbal Products Div. - Benchtop Laboratory Equipment Ops & Director of Marketing

    • Tenure: 0yrs
    • Compensation: US$187.10k
  • Anthony Mitri (37yo)

    President of Altamira

    • Tenure: 2.4yrs
    • Compensation: US$131.30k

Board Members

  • Helena Santos (55yo)

    CEO, President

    • Tenure: 17.2yrs
    • Compensation: US$198.30k
  • James Segasture (83yo)

    Director

    • Tenure: 28.8yrs
    • Compensation: US$16.80k
  • John Moore (54yo)

    Director

    • Tenure: 0.8yrs
    • Compensation: US$61.80k
  • Joseph Cremonese (83yo)

    Chairman

    • Tenure: 13.7yrs
    • Compensation: US$84.40k
  • Marcus Frampton

    Director

    • Tenure: 0.6yrs
    • Compensation: US$2.80k
  • Grace Morin (71yo)

    Director

    • Tenure: 12.8yrs
    • Compensation: US$39.00k
  • John F. Watkins (52yo)

    Director

    • Tenure: 2.8yrs
    • Compensation: US$20.80k

Company Information

Scientific Industries, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Scientific Industries, Inc.
  • Ticker: SCND
  • Exchange: OTCPK
  • Founded: 1954
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$14.568m
  • Shares outstanding: 1.49m
  • Website: https://www.scientificindustries.com

Number of Employees


Location

  • Scientific Industries, Inc.
  • 80 Orville Drive
  • Suite 102
  • Bohemia
  • New York
  • 11716
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SCNDOTCPK (Pink Sheets LLC)YesCommon StockUSUSDDec 1972

Biography

Scientific Industries, Inc. provides benchtop laboratory equipment, customized catalyst research instruments, and bioprocessing systems and products worldwide. It offers vortex mixers to mix the contents o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 23:42
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.